Infectious diseases

Haiti Celebrates Major Progress Against Malaria on World Malaria Day

Retrieved on: 
Thursday, April 25, 2019
Infectious diseases, Countries, Malaria, Medical specialties, Tropical diseases, Haiti, Republics, World Malaria Day

WASHINGTON, April 25, 2019 /PRNewswire-PRWeb/ -- This World Malaria Day, members of the global health community laud the dedication of thousands of Haitian health workers committed to accelerating efforts to eliminate malaria in Haiti.

Key Points: 
  • WASHINGTON, April 25, 2019 /PRNewswire-PRWeb/ -- This World Malaria Day, members of the global health community laud the dedication of thousands of Haitian health workers committed to accelerating efforts to eliminate malaria in Haiti.
  • By 2017, Grand'Anse, a remote region in southwestern Haiti, carried more than 50 percent of the island nation's malaria burden.
  • "This World Malaria Day, I congratulate Haiti on its incredible momentum in the battle to end malaria," said Dr. Michelle Chang, Director of Malaria Zero, and CDC Medical Epidemiologist.
  • About Malaria Zero: Malaria Zero has one bold goal: to eliminate malaria from the island of Hispaniola, which includes Haiti and the Dominican Republic.

United States Infectious Disease Molecular Diagnostics Market 2019: Supplier Shares by Test, Volume and Sales, Competitive Strategies, Innovative Technologies, & Instrumentation Review - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 25, 2019
Health, Infectious diseases, Biotechnology, Molecular diagnostics, Life sciences, Medicine, Branches of biology, Qiagen

The "2019 US Infectious Disease Molecular Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2019 US Infectious Disease Molecular Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review" report has been added to ResearchAndMarkets.com's offering.
  • This new study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
  • The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry.
  • Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.

United States Microbiology Market Report 2019: Forecast Volumes and Sales for Over 100 Infectious Disease Tests - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 25, 2019
Health, Infectious diseases, Market economics), Microeconomics, Marketing, Business economics, Market segmentation, Market share

The "2019 US Microbiology Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2019 US Microbiology Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers" report has been added to ResearchAndMarkets.com's offering.
  • The report presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.
  • Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.
  • Volume and sales forecasts for over 100 infectious disease assays by individual test and market segment:

Cerus Corporation to Release First Quarter 2019 Results on May 7, 2019

Retrieved on: 
Thursday, April 25, 2019
Health, Biotechnology, Infectious diseases, Medical devices, Transfusion medicine, Blood, Blood transfusion, Hematology, Transfusion

Cerus Corporation (Nasdaq:CERS) announced today that its first quarter 2019 results will be released on Tuesday, May 7, 2019, after the close of the stock market.

Key Points: 
  • Cerus Corporation (Nasdaq:CERS) announced today that its first quarter 2019 results will be released on Tuesday, May 7, 2019, after the close of the stock market.
  • ET that afternoon, during which management will discuss the Companys financial results and provide a general business overview and outlook.
  • To access the live webcast, please visit the Investor Relations page of the Cerus website at http://www.cerus.com/ir .
  • Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety.

Verrix to Exhibit at International Association of Healthcare Central Service Material Management 2019 Annual Conference

Retrieved on: 
Thursday, April 25, 2019
Surgery, Technology, Hardware, Practice Management, Health, Biotechnology, Hospitals, Infectious diseases, Medical devices, Other Science, Medical Supplies, Nursing, Science, Managed care, Health, Medical specialties, Medicine, Infectious diseases, Epidemiology, Healthcare quality, Infection control, Sterilization, Adrian Ponce, Hospital-acquired infection, Infection

Meet Adrian Ponce, Ph.D., Verrix Founder/Inventor and NASA Jet Propulsion Laboratory Scientist, on Monday, April 29, 15 p.m. PDT.

Key Points: 
  • Meet Adrian Ponce, Ph.D., Verrix Founder/Inventor and NASA Jet Propulsion Laboratory Scientist, on Monday, April 29, 15 p.m. PDT.
  • Interview the Verrix team of scientists and commercial partners working to develop solutions for accurate and rapid sterilization confirmation.
  • Verrix is a San Clemente, Calif.-based medical device company that is using the most advanced technologies to help protect patients from healthcare-associated infections.
  • Based on scientific expertise and close partnerships with healthcare professionals, Verrix is developing market-changing solutions for sterility assurance, environmental monitoring, and infection control.

Germ-Zapping Robots Enhance Aultman Hospital’s Robust Infection Prevention Program

Retrieved on: 
Thursday, April 25, 2019
Technology, Other Technology, Health, Biotechnology, Hospitals, Infectious diseases, Medical specialties, Health, Medicine, Infectious diseases, Hygiene, Healthcare-associated infections, Bacterial diseases, Epidemiology, Aultman Hospital, Methicillin-resistant Staphylococcus aureus, Infection rate, Antimicrobial stewardship

When it comes to infection prevention, we have a comprehensive program in place that includes antibiotic stewardship, hand hygiene and education, to name just a few of our best practices.

Key Points: 
  • When it comes to infection prevention, we have a comprehensive program in place that includes antibiotic stewardship, hand hygiene and education, to name just a few of our best practices.
  • Xenex LightStrike robots have been credited by numerous health care facilities for helping them reduce their infection rates significantly.
  • Several hospitals have published their 46-100 percent C.diff, MRSA and/or surgical site infection rate reduction studies in peer-reviewed journals .
  • The vertically integrated institution includes Aultman Hospital, Aultman Orrville Hospital, Alliance Community Hospital, the locally managed health insurance provider AultCare, The Aultman Foundation and Aultman College.

2019 Infectious Disease Diagnostics Market Report: Supplier Shares by Country and Strategic Assessments of Leading Suppliers - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 25, 2019
Health, Infectious diseases, Branches of biology, Biology, Medical specialties, Biotechnology, Immune system, Immunology, Biochip, Molecular biology, Proteomics, Antibody, Monoclonal antibody, Infection

The "2019 Infectious Disease Diagnostics Market: Supplier Shares by Country and Strategic Assessments of Leading Suppliers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2019 Infectious Disease Diagnostics Market: Supplier Shares by Country and Strategic Assessments of Leading Suppliers" report has been added to ResearchAndMarkets.com's offering.
  • This report provides detailed analyses of current and emerging Technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scattering, chromatography and several others.
  • The report also presents strategic assessments of leading market players and emerging suppliers with innovative Technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Global Infectious Disease Molecular Diagnostics Market 2019: Supplier Shares, Competitive Strategies, Innovative Technologies, & Instrumentation Review - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 25, 2019
Health, Infectious diseases, Medical tests, Medicine, Biotechnology, Molecular diagnostics, Life sciences, Branches of biology, Qiagen, Innogenetics

This new study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Key Points: 
  • This new study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.
  • The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular Technologies as corporate strategic assets, managed in support of business and marketing strategies.

Fruit Linked Salmonella Outbreak Tops 117 in 10 States

Retrieved on: 
Thursday, April 25, 2019
Infectious diseases, Medical specialties, Medicine, Enterobacteriaceae, Gram-negative bacteria, Pathogenic bacteria, Salmonella, Ground turkey, Salmonellosis, Outbreak of Salmonella

Food and Drug Administration are investigating a multistate outbreak ofSalmonellaCarrau infections that has sickened 117 in 10 states, putting 32 in the hospital.

Key Points: 
  • Food and Drug Administration are investigating a multistate outbreak ofSalmonellaCarrau infections that has sickened 117 in 10 states, putting 32 in the hospital.
  • However, we need answers from Caito Foods LLC why they have had two multistate Salmonella outbreaks in two years this is unacceptable."
  • As of April 24, 2019, 117 people infected with the outbreak strain ofSalmonellaCarrau have been reported from 10 states Minnesota, Iowa, Missouri, Michigan, Illinois, Wisconsin, Indiana, Ohio, Kentucky and Alabama.
  • Our Salmonella lawyers have represented victims of notable Salmonella outbreaks such as the 2004 Sheetz and Coronet Foods tomato Salmonella outbreak, the 2009 PCA peanut Salmonella outbreak, and the 2011 Cargill ground turkey antibiotic-resistant Salmonella outbreak.

Minister of Health announces partnerships to improve vaccination rates in Canada

Retrieved on: 
Thursday, April 25, 2019
Medical specialties, RTT, Medicine, Infectious diseases, Pediatrics, Vaccine-preventable diseases, Vaccination, Biotechnology, Vaccine, Measles, Whooping cough, Vaccine hesitancy

Vaccination is the most effective way to prevent the spread of serious diseases like measles, whooping cough and the flu in our communities.

Key Points: 
  • Vaccination is the most effective way to prevent the spread of serious diseases like measles, whooping cough and the flu in our communities.
  • Recognizing that some Canadians face challenges in accessing vaccines, the Honourable Ginette Petitpas Taylor, Minister of Health, today announced a new project with the Fraser Health Authority in British Columbia to improve access to vaccination and increase vaccine coverage for two-year olds in the Surrey region.
  • It will focus on improving services for hard-to-reach and lowincome families, as well as Indigenous people and newcomers to Canada.
  • Since the launch of the Immunization Partnership Fund (IPF) in 2016, 19 projects have been funded across Canada to support innovative approaches to increasing vaccination acceptance and uptake in Canada.